Novaplus Logo (Image 01)
Mesna Injection, Solution
Product Images NDC 10019-951
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mesna (NDC 10019-951). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Representative Mesna Novaplus Container Label Ndc 10019-951-10 (Image 02)
This is a description of a Mesna injection medication from Baxter Healthcare Corporation. It is a 1 Multidose Vial which contains 1 gram of Mesna for intravenous use with % benzyl alcohol being an additive. It also notes the trademark registered to Vizient, Inc. The dosing information is provided in an insert and it should be stored at a controlled room temperature of 20°C-25°C. The NDC number is 10019-951-10.*
Representative Mesna Novaplus Carton Label Ndc 10019-951-05 (Image 03)
This is a description for a product designed for intravenous use. It is a 1 Multidose Vial containing 10 mL water and 10% sodium-Z-marcapioathana sulfnato, also known as mesna. This solution is sterile, non-pyrogenic and contains preservatives. The appropriate dosage should be administered by following the package insert directions. The manufacturer is Baxter Healthcare Corporation, located in Deerfield, Illinois, USA. The solution should be stored at a temperature between 20°C and 5°C, with excursions to 15°-2°C permitted. The text contains pharmaceutical jargon and information, typical in descriptions of medical products.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
